Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army.

Michael Gale, Adjunct Professor of Global Health and Professor of Immunology in the UW School of Medicine, is quoted. Steven Reed, Affiliate Professor of Global Health and CEO of HDT Bio, is featured.